Germany · Delayed Price · Currency is EUR Ventripoint Diagnostics Company Description
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.
The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
| Country | Canada |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| CEO | Hugh MacNaught |
Contact Details
Address: 18 Hook Avenue Toronto, Alberta M6P 1T4 Canada | |
| Phone | 416 848 4156 |
| Website | ventripoint.com |
Stock Details
| Ticker Symbol | 5V7 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Hugh MacNaught | Chief Executive Officer |
| Jimmy Jeon | Chief Financial Officer |